Albright's Hereditary Osteodystrophy Overview

Save information for later
Sign Up

Learn About Albright's Hereditary Osteodystrophy

What is the definition of Albright's Hereditary Osteodystrophy?
Albright's hereditary osteodystrophy (AHO) is a rare disorder with a wide range of signs and symptoms, including short stature, obesity, round face, subcutaneous ossifications (formation of bone under the skin), and short fingers and toes (brachydactyly). When the disorder is inherited from the mother, the features of AHO can be associated with resistance to certain hormones, in particular the parathyroid hormone (PTH). This is called pseudohypoparathyroidism type 1a (PHP1a). When inherited from the father, an individual will have AHO without any hormone issues, which is called pseudopseudohypoparathyroidism (PPHP). This condition is inherited in an autosomal dominant manner due to a genetic change in the GNAS gene.
What are the alternative names for Albright's Hereditary Osteodystrophy?
  • Albright's hereditary osteodystrophy
  • Pseudohypoparathyroidism type 1A
  • Pseudopseudohypoparathyroidism
  • AHO
  • Albright hereditary osteodystrophy
  • Pseudohypoparathyroidism with Albright hereditary osteodystrophy
  • Albright hereditary osteodystrophy with multiple hormone resistance
  • PHP1A
  • Albright hereditary osteodystrophy without multiple hormone resistance
  • PPHP
  • Pseudo-Pseudohypoparathyroidism
  • Pseudopseudo-Hypoparathyroidism
Who are the top Albright's Hereditary Osteodystrophy Local Doctors?
Elite in Albright's Hereditary Osteodystrophy
Giovanna R. Mantovani
Elite in Albright's Hereditary Osteodystrophy
Giovanna R. Mantovani
R. Maestro Cardim 769, Bela Vista, 
Sao Paulo, SP, BR 

Giovanna Mantovani practices in Sao Paulo, Brazil. Ms. Mantovani is rated as an Elite expert by MediFind in the treatment of Albright's Hereditary Osteodystrophy. Her top areas of expertise are Albright's Hereditary Osteodystrophy, Pseudohypoparathyroidism, Progressive Osseous Heteroplasia, Hormone Replacement Therapy (HRT), and Endoscopic Transnasal Transsphenoidal Surgery.

Elite in Albright's Hereditary Osteodystrophy
Agnes Linglart
Elite in Albright's Hereditary Osteodystrophy
Agnes Linglart
INSERM U1185, 64 Gabriel Péri Street, 
Paris, FR 

Agnes Linglart practices in Paris, France. Ms. Linglart is rated as an Elite expert by MediFind in the treatment of Albright's Hereditary Osteodystrophy. Her top areas of expertise are X-Linked Hypophosphatemia, Hypophosphatemia, Rickets, Pseudohypoparathyroidism, and Osteotomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Albright's Hereditary Osteodystrophy
Francesca M. Elli
Elite in Albright's Hereditary Osteodystrophy
Francesca M. Elli
Milan, IT 

Francesca Elli practices in Milan, Italy. Ms. Elli is rated as an Elite expert by MediFind in the treatment of Albright's Hereditary Osteodystrophy. Her top areas of expertise are Albright's Hereditary Osteodystrophy, Pseudohypoparathyroidism, Progressive Osseous Heteroplasia, Acrodysostosis, and Kidney Transplant.

View All Doctors
What are the latest Albright's Hereditary Osteodystrophy Clinical Trials?
Natural History Study of Parathyroid Disorders
Natural History Study of Parathyroid Disorders
Enrollment Status: Recruiting
Publish Date: November 26, 2025

Background: Parathyroid disorders are very common in the general population and include disorders of parathyroid excess, deficiency, or defects in parathyroid hormone (PTH) signaling. PTH, the main secretory product of parathyroid glands is responsible for regulation of calcium-phosphate homeostasis.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Natural History Study of Albright Hereditary Osteodystrophy: Includes Substudies on Effects of Growth Hormone in Patients With Pseudohypoparathyroidism Type 1A and Cognitive & Behavioral Studies in Albright Hereditary Osteodystrophy
Natural History Study of Albright Hereditary Osteodystrophy: Includes Substudies on Effects of Growth Hormone in Patients With Pseudohypoparathyroidism Type 1A and Cognitive & Behavioral Studies in Albright Hereditary Osteodystrophy
Enrollment Status: Recruiting
Publish Date: May 28, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable

Summary: We, the researchers, are following the natural history of Albright hereditary osteodystrophy. We have found that growth hormone deficiency is very common in patients with pseudohypoparathyroidism type 1A, which falls under the broader condition termed Albright hereditary osteodystrophy. Patients with pseudohypoparathyroidism type 1A typically are short and obese. Some of these patients are not sho...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center